Vann Equity Management LLC

Position in NVS — Novartis AG

CIK 2018412 PLANO, TX

Position in NVS

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$350,739

+$9,954 QoQ

Shares Held

2,238

+0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#1,050

of 1,603 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Vann Equity Management LLC holds $6,004,882 across 6 Drug Manufacturers - General names. NVS ranks #5 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,707	$3,246,857
2	ABBV	AbbVie Inc.	5,541	$1,394,337
3	GILD	Gilead Sciences, Inc.	3,332	$420,964
4	MRK	Merck & Co., Inc.	2,783	$357,615
5	NVS	Novartis AG This page	2,238	$350,739
6	AZN	Astrazeneca PLC	1,236	$234,370

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$350,739	2,238	+0.3%	Shares	Sole	2026-08-05
2026-03-31	$340,785	2,231	—	Shares	Sole	2026-05-08
No filing history on record for this holder in this stock.